REQUEST A DEMO
Total
USD $0.00
Search more companies

Bonapharm Ecuador C.L. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Medicinal and Botanical Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Bonapharm Ecuador C.L. Profile Updated: April 07, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Bonapharm Ecuador C.L. is a company based in Ecuador, with its head office in Guayaquil. It operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on February 27, 2020. It currently has a total number of 24 (2024) employees. The latest financial highlights indicate a net sales revenue increase of 284.84% in 2025. Its total assets grew by 11.63% over the same period. The net profit margin of Bonapharm Ecuador C.L. increased by 318.22% in 2025.

Headquarters
Av. Rodriguez Chavez, 3
Guayaquil; Guayas;

Contact Details: Purchase the Bonapharm Ecuador C.L. report to view the information.

Basic Information
Total Employees:
Purchase the Bonapharm Ecuador C.L. report to view the information.
Registered Capital:
Purchase the Bonapharm Ecuador C.L. report to view the information.
Financial Auditors:
Purchase the Bonapharm Ecuador C.L. report to view the information.
Incorporation Date:
February 27, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Bonapharm Ecuador C.L. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
284.84%
Total Operating Revenue
170.8%
Operating Profit
74.68%
EBITDA
75.39%
Net Profit/Loss for the Period
71.01%
Total Assets
11.63%
Total Equity
-25.11%
Operating Profit Margin
321.5%
Net Profit Margin
318.22%
Return on Equity (ROE)
-66.53%
Quick Ratio
-0.03%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?